Vericel (VCEL) Research & Development (2010 - 2026)

Vericel's (VCEL) quarterly Research & Development came in at $8.1 million in Q1 2026, up 11.61% year-on-year from $7.3 million in Q1 2025, and up 11.73% quarter-over-quarter from $7.3 million in Q4 2025.

Vericel (VCEL) Research & Development (2010 - 2026) Analysis & Trends

Vericel has disclosed Research & Development across 17 years of filings, most recently posting $8.1 million for Q1 2026.

  • Research & Development for Q1 2026 came in at $8.1 million, up 11.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.4 million (up 10.79% YoY), and the FY2025 annual result was $27.6 million, up 11.15% from the prior year.
  • Research & Development came in at $8.1 million for Q1 2026 at Vericel, up from $7.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $8.1 million in Q1 2026 to a low of $4.8 million in Q2 2022.
  • The 5-year median for Research & Development is $5.7 million (2023), against an average of $6.0 million.
  • Peak annual rise in Research & Development reached 47.33% in 2025, while the deepest fall reached 8.58% in 2025.
  • Vericel's Research & Development stood at $5.2 million in 2022, then declined by 6.56% to $4.9 million in 2023, then rose by 0.45% to $4.9 million in 2024, then jumped by 47.33% to $7.3 million in 2025, then advanced by 11.73% to $8.1 million in 2026.
  • The last three Research & Development figures came in at $8.1 million (Q1 2026), $7.3 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 8.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.10 Mn
Dec 31, 2025 7.25 Mn
Sep 30, 2025 6.32 Mn
Jun 30, 2025 6.73 Mn
Mar 31, 2025 7.26 Mn
Dec 31, 2024 4.92 Mn
Sep 30, 2024 6.09 Mn
Jun 30, 2024 7.36 Mn
Mar 31, 2024 6.42 Mn
Dec 31, 2023 4.90 Mn
Sep 30, 2023 5.68 Mn
Jun 30, 2023 5.25 Mn
Mar 31, 2023 5.21 Mn
Dec 31, 2022 5.25 Mn
Sep 30, 2022 5.05 Mn
Jun 30, 2022 4.79 Mn
Mar 31, 2022 4.86 Mn
Dec 31, 2021 3.92 Mn
Sep 30, 2021 4.28 Mn
Jun 30, 2021 4.45 Mn